600
Participants
Start Date
February 28, 2003
Primary Completion Date
June 30, 2007
Study Completion Date
June 30, 2007
AVP-923
Hospital for Joint Diseases MS Care Center, New York
Upstate Clinical Research, Albany
SUNY Upstate Medical University, Syracuse
DENT Neurologic Group L.L.P., Amherst
Westmoreland Neurology, Greensburg
Lehigh Valley Neurosciences and Pain Research Center, Allentown
Neurological Associates of Delaware Valley, Upland
Jenkintown
MCP-Hahnemann University, Philadelphia
Penn Neurological Institute, Philadelphia
George Washington University Medical Faculty Assoc., Washington D.C.
Raleigh Neurology Associates, PA, Raleigh
Carolinas Medical Center, Charlotte
Neurology & Headache Specialist of Atlanta, L.L.C., Decatur
University of Miami Dept. of Neurology, Miami
Miami Jewish Home & Hospital for the Aged, Miami
Allied Clinical Trials, Miami
Renstar Medical Research, Plantation
Neurological Associates, Fort Lauderdale
Tampa
Suncoast Neuroscience Associates Inc., St. Petersburg
MetroHealth Medical Center, Cleveland
University Memory and Aging Center, Cleveland
The Cleveland Clinic Foundation, Cleveland
NeuroCare Center, Inc., Canton
University of Wisconsin, Madison
Advanced Neurology Specialists, Great Falls
Consultants in Neurology LTD, Northbrook
Neurological Associates, P.C., Lincoln
Clinical Pharmaceutical Trials, Inc., Tulsa
Methodist Neurological Institute, Houston
Claghorn-Lesem Research Clinic, Bellaire
Barrow Neurological Institute, Phoenix
UCLA School of Medicine, Los Angeles
Center for Neurologic Study, La Jolla
UCSF, San Francisco
Neurology and Neurosurgery Associates of Tacoma, Tacoma
Research Center for Clinical Studies, Inc., Darien
Fletcher Allen Health Care, Burlington
Lead Sponsor
Avanir Pharmaceuticals
INDUSTRY